BlackRock Health Sciences Term Trust (BMEZ) Stock
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
BlackRock Health Sciences Term Trust is headquartered in US.
BlackRock Health Sciences Term Trust (BMEZ) stock trades at $16.15 with a market capitalization of $1.64B. The stock is valued at a price-to-earnings (P/E) ratio of 7.50, price-to-book of 1.01, price-to-sales of 21.59. Over the past 52 weeks the stock has ranged between $13.70 and $16.20, and currently trades at its 52-week high.
On profitability, BlackRock Health Sciences Term Trust generates a return on equity (ROE) of 14.30%, above the typical market average, return on capital employed of 14.30%, an operating margin of 305.20%, a net profit margin of 288.16%.
Official website: www.blackrock.com